Cervical Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Cervical Cancer, including details on symptoms, vaccine, screening, treatment, human papilloma virus (hpv), information.

Volume 3 (2006), Issue 2 (February)

1. A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening.
   Int J Cancer, 118(4): 791-6. [Abstract] [Full-text]
2. Direct comparison of liquid-based and conventional cytology in a South African screening trial.
   Int J Cancer, 118(4): 957-62. [Abstract] [Full-text]
3. Detection of human papillomavirus type 18 E6 and E7-specific CD4+ T-helper 1 immunity in relation to health versus disease.
   Int J Cancer, 118(4): 950-6. [Abstract] [Full-text]
4. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis.
   Lancet, 367(9509): 489-98. [Abstract] [Full-text]
5. Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis.
   Int J Cancer, 118(8): 1892-900. [Abstract] [Full-text]
6. Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: frequent PIK3CA amplification and AKT phosphorylation.
   Int J Cancer, 118(8): 1877-83. [Abstract] [Full-text]
7. Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia.
   Int J Cancer, 118(8): 2048-55. [Abstract] [Full-text]
8. Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.
   Int J Cancer, 118(9): 2168-71. [Abstract] [Full-text]
9. Early determination of uterine cervical squamous cell carcinoma radioresponse identifies high- and low-response tumors.
   Int J Radiat Oncol Biol Phys, 64(4): 1179-82. [Abstract] [Full-text]
10. p16INK4A expression in cervical premalignant and malignant lesions.
    Exp Mol Pathol, 80(2): 192-6. [Abstract] [Full-text]
11. Successful term delivery following conservative management for villoglandular papillary adenocarcinoma of the uterine cervix: A case report.
    Gynecol Oncol, 101(1): 168-71. [Abstract] [Full-text]
12. Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model.
    Gynecol Oncol, 101(1): 46-54. [Abstract] [Full-text]
13. Diagnostic and therapeutic laser conization for cervical intraepithelial neoplasia.
    Gynecol Oncol, 101(1): 143-6. [Abstract] [Full-text]
14. Effects of human papillomavirus type 16 E7 protein on the growth of cervical carcinoma cells and immuno-escape through the TGF-beta1 signaling pathway.
    Gynecol Oncol, 101(1): 132-9. [Abstract] [Full-text]
15. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy.
    Gynecol Oncol, 101(1): 147-51. [Abstract] [Full-text]

© 2004-2010 Cervical Cancer Research Today. All Rights Reserved.